Connecting you to content on EBSCOhost

Works by Dahl, Goran

Results: 5

1

Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma.

Published in:

Drug Design, Development & Therapy, 2022, v. 16, p. 2901, doi. 10.2147/DDDT.S354291

By:

Nilsson, Magnus;
Rhedin, Magdalena;
Hendrickx, Ramon;
Berglund, Susanne;
Piras, Antonio;
Blomgran, Parmis;
Cavallin, Anders;
Collins, Mia;
Dahl, Göran;
Dekkak, Bilel;
Ericsson, Therese;
Hagberg, Niklas;
Holmberg, Ann Aurell;
Leffler, Agnes;
Lundqvist, Anders J;
Markou, Thomais;
Pinkerton, James;
Rönnblom, Lars;
Siu, Stacey;
Taylor, Vanessa

Publication type:

Article

2

Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors.

Published in:

Journal of Molecular Recognition, 2011, v. 24, n. 1, p. 60, doi. 10.1002/jmr.1023

By:

Geitmann, Matthis;
Dahl, Göran;
Danielson, U. Helena

Publication type:

Article

3

Proteolysis-targeting chimeras in drug development: A safety perspective.

Published in:

2020

By:

Moreau, Kevin;
Coen, Muireann;
Zhang, Andrew X.;
Pachl, Fiona;
Castaldi, M. Paola;
Dahl, Goran;
Boyd, Helen;
Scott, Clay;
Newham, Pete

Publication type:

journal article

4

Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3.

Published in:

FEBS Journal, 2007, v. 274, n. 22, p. 5979, doi. 10.1111/j.1742-4658.2007.06120.x

By:

Dahl, Göran;
Sandström, Anja;
Åkerblom, Eva;
Danielson, U. Helena

Publication type:

Article

5

A Comparative Study of Fluorescence Assays in Screening for BRD4.

Published in:

Assay & Drug Development Technologies, 2018, v. 16, n. 7, p. 372, doi. 10.1089/adt.2018.850

By:

Hansson, Pia;
Boyd, Helen;
Dale, Ian L.;
Dahl, Göran;
Nicolaus, Felix;
Bowen, Wayne;
Doering, Klaus;
Dunsmore, Colin;
Cotton, Graham;
Lindmark, Helena

Publication type:

Article